Korean generic drug exporters advised to cultivate markets in advanced countries

Published: 2004-05-11 07:00:00

Updated: 2004-05-11 07:00:00

With the growing trend of accelerated consumer access to generic drugs and large reimbursement price cuts in advanced countries such as the US and Japan, market analysts proposed domestic generic exporters put their priority on these markets to meet the surging generic demand and regain Korea's f...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK